David Yang

2.1k total citations
10 papers, 1.6k citations indexed

About

David Yang is a scholar working on Immunology, Ophthalmology and Oncology. According to data from OpenAlex, David Yang has authored 10 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Immunology, 3 papers in Ophthalmology and 3 papers in Oncology. Recurrent topics in David Yang's work include Ocular Diseases and Behçet’s Syndrome (3 papers), Immunotherapy and Immune Responses (2 papers) and Glioma Diagnosis and Treatment (2 papers). David Yang is often cited by papers focused on Ocular Diseases and Behçet’s Syndrome (3 papers), Immunotherapy and Immune Responses (2 papers) and Glioma Diagnosis and Treatment (2 papers). David Yang collaborates with scholars based in United States, Australia and United Kingdom. David Yang's co-authors include Amy B. Heimberger, Dima Suki, Kenneth Aldape, S. Farzana Hussain, Elizabeth A. Grimm, Raymond Sawaya, Mark R. Gilbert, Roman Hlatky, Mohamed Abou-Ghazal and Chantal Reina-Ortiz and has published in prestigious journals such as Clinical Cancer Research, Annals of the Rheumatic Diseases and Neurosurgery.

In The Last Decade

David Yang

10 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Yang United States 9 797 720 692 429 285 10 1.6k
Nikki Charles United States 8 581 0.7× 998 1.4× 709 1.0× 940 2.2× 647 2.3× 9 2.2k
Stephanie M. Pyonteck United States 7 1.8k 2.2× 629 0.9× 831 1.2× 761 1.8× 272 1.0× 7 2.6k
Garima Yagnik United States 15 540 0.7× 423 0.6× 352 0.5× 579 1.3× 283 1.0× 25 1.3k
Serena Pellegatta Italy 27 748 0.9× 738 1.0× 1.0k 1.5× 986 2.3× 513 1.8× 69 2.3k
Verlene Henry United States 14 468 0.6× 446 0.6× 473 0.7× 544 1.3× 290 1.0× 17 1.2k
Rikke Rasmussen Denmark 10 532 0.7× 540 0.8× 452 0.7× 728 1.7× 293 1.0× 12 1.4k
Horacio Soto United States 18 697 0.9× 565 0.8× 759 1.1× 661 1.5× 414 1.5× 28 1.7k
Orsolya Rajky Austria 9 444 0.6× 661 0.9× 786 1.1× 199 0.5× 126 0.4× 14 1.3k
Yvonne Kienast Germany 14 492 0.6× 423 0.6× 981 1.4× 940 2.2× 480 1.7× 22 2.2k
Corina Taitt United States 7 396 0.5× 621 0.9× 659 1.0× 230 0.5× 145 0.5× 14 1.2k

Countries citing papers authored by David Yang

Since Specialization
Citations

This map shows the geographic impact of David Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Yang more than expected).

Fields of papers citing papers by David Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Yang. The network helps show where David Yang may publish in the future.

Co-authorship network of co-authors of David Yang

This figure shows the co-authorship network connecting the top 25 collaborators of David Yang. A scholar is included among the top collaborators of David Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Yang. David Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Lightman, Susan, Simon Taylor, Catey Bunce, et al.. (2014). Pegylated interferon-α-2b reduces corticosteroid requirement in patients with Behçet’s disease with upregulation of circulating regulatory T cells and reduction of Th17. Annals of the Rheumatic Diseases. 74(6). 1138–1144. 46 indexed citations
2.
Yang, David, et al.. (2012). A novel treatment of central serous chorioretinopathy with topical anti-inflammatory therapy. BMJ Case Reports. 2012. bcr2012006970–bcr2012006970. 10 indexed citations
3.
Yang, David, et al.. (2009). Upregulation of Foxp3 Expression by Recombinant Interferon-alpha Therapy in Behcet’s Disease. Investigative Ophthalmology & Visual Science. 50(13). 1535–1535. 5 indexed citations
4.
Abou-Ghazal, Mohamed, David Yang, Wei Qiao, et al.. (2008). The Incidence, Correlation with Tumor-Infiltrating Inflammation, and Prognosis of Phosphorylated STAT3 Expression in Human Gliomas. Clinical Cancer Research. 14(24). 8228–8235. 155 indexed citations
5.
Abou-Ghazal, Mohamed, Ling‐Yuan Kong, Chantal Reina-Ortiz, et al.. (2008). The Role of Tregs in Human Glioma Patients and their Inhibition with a Novel STAT-3 Inhibitor. Neurosurgery. 62(6). 1423–1423. 17 indexed citations
6.
Heimberger, Amy B., Mohamed Abou-Ghazal, Chantal Reina-Ortiz, et al.. (2008). Incidence and Prognostic Impact of FoxP3+ Regulatory T Cells in Human Gliomas. Clinical Cancer Research. 14(16). 5166–5172. 255 indexed citations
7.
Hussain, S. Farzana, David Yang, Dima Suki, et al.. (2006). The role of human glioma-infiltrating microglia/macrophages in mediating antitumor immune responses1. Neuro-Oncology. 8(3). 261–279. 475 indexed citations
8.
Hussain, S. Farzana, et al.. (2006). Innate immune functions of microglia isolated from human glioma patients. Journal of Translational Medicine. 4(1). 15–15. 83 indexed citations
9.
Heimberger, Amy B., Dima Suki, David Yang, Weiming Shi, & Kenneth Aldape. (2005). The natural history of EGFR and EGFRvIII in glioblastoma patients. Journal of Translational Medicine. 3(1). 38–38. 180 indexed citations
10.
Heimberger, Amy B., Roman Hlatky, Dima Suki, et al.. (2005). Prognostic Effect of Epidermal Growth Factor Receptor and EGFRvIII in Glioblastoma Multiforme Patients. Clinical Cancer Research. 11(4). 1462–1466. 415 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026